MedPath

Postoperative nausea and vomiting after general anesthesia with Remimazolam.

Not Applicable
Conditions
General anesthesia
Registration Number
JPRN-jRCT1041210079
Lead Sponsor
Suzuki Yuji
Brief Summary

A retrospective, observational, single-center cohort study comparing the occurrence of postoperative nausea and vomiting with remimazolam and propofol anesthesia was conducted. Bias in anesthetic selection was adjusted for using propensity score matching techniques. A total of 1239 subjects were included and 333 pairs were created. Remimazolam anesthesia was associated with a higher incidence of postoperative nausea and vomiting than propofol anesthesia and was robust after propensity score adjustment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
4933
Inclusion Criteria

All patients who had undergone surgery under general anesthesia at Hamamatsu University Hospital since August 2020.

Exclusion Criteria

less than 20 years of age, incorrect enrollment other than general anesthesia, postoperative artificial respiration, cancellation of surgery after induction of anesthesia, lack of consciousness after anesthesia, reoperation within 24 hours after anesthesia, insufficient data due to follow-up shorter than 24 hours, and maintenance with a combination of propofol and remimazolam.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of postoperative nausea and vomiting
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath